EP1534346A4 - Toluidinblau-o-arzneisubstanz und ihre verwendung fur die anfarbung in vivo und fur die chemotherapeutische behandlung von dysplastischem gewebe - Google Patents

Toluidinblau-o-arzneisubstanz und ihre verwendung fur die anfarbung in vivo und fur die chemotherapeutische behandlung von dysplastischem gewebe

Info

Publication number
EP1534346A4
EP1534346A4 EP02739681A EP02739681A EP1534346A4 EP 1534346 A4 EP1534346 A4 EP 1534346A4 EP 02739681 A EP02739681 A EP 02739681A EP 02739681 A EP02739681 A EP 02739681A EP 1534346 A4 EP1534346 A4 EP 1534346A4
Authority
EP
European Patent Office
Prior art keywords
drug substance
toluidine blue
chemotherapeutic treatment
vivo staining
dysplastic tissues
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP02739681A
Other languages
English (en)
French (fr)
Other versions
EP1534346A2 (de
Inventor
Karl Okolotowicz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zila Inc
Original Assignee
Zila Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zila Inc filed Critical Zila Inc
Publication of EP1534346A2 publication Critical patent/EP1534346A2/de
Publication of EP1534346A4 publication Critical patent/EP1534346A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B21/00—Thiazine dyes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/006—Biological staining of tissues in vivo, e.g. methylene blue or toluidine blue O administered in the buccal area to detect epithelial cancer cells, dyes used for delineating tissues during surgery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Physics & Mathematics (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Optics & Photonics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
EP02739681A 2002-06-04 2002-06-04 Toluidinblau-o-arzneisubstanz und ihre verwendung fur die anfarbung in vivo und fur die chemotherapeutische behandlung von dysplastischem gewebe Withdrawn EP1534346A4 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2002/017720 WO2003103569A2 (en) 2002-06-04 2002-06-04 Toluidine blue o drug substance and use thereof for in vivo staining and chemotherapeutic treatment of dysplastic tissues

Publications (2)

Publication Number Publication Date
EP1534346A2 EP1534346A2 (de) 2005-06-01
EP1534346A4 true EP1534346A4 (de) 2007-07-25

Family

ID=29731309

Family Applications (1)

Application Number Title Priority Date Filing Date
EP02739681A Withdrawn EP1534346A4 (de) 2002-06-04 2002-06-04 Toluidinblau-o-arzneisubstanz und ihre verwendung fur die anfarbung in vivo und fur die chemotherapeutische behandlung von dysplastischem gewebe

Country Status (9)

Country Link
EP (1) EP1534346A4 (de)
JP (1) JP2005535605A (de)
CN (1) CN1302815C (de)
AU (1) AU2002312319A1 (de)
BR (1) BRPI0215775A2 (de)
IL (1) IL165516A0 (de)
MX (1) MXPA04012031A (de)
TW (1) TW200733956A (de)
WO (1) WO2003103569A2 (de)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999025388A1 (en) * 1997-11-13 1999-05-27 Zila, Inc. In vivo stain composition, process of manufacture, and methods of use to identify dysplastic tissue
WO2001064255A1 (en) * 2000-02-28 2001-09-07 Zila, Inc. Method for detecting and killing epithelial cancer cells

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH071257B2 (ja) * 1985-09-09 1995-01-11 エスエス製薬株式会社 混合ビタミン剤中の水溶性ビタミン類の同時定量法
JPS6410171A (en) * 1987-07-03 1989-01-13 Shimadzu Corp Analysis of amino acid
CA2097695C (en) * 1991-10-31 2000-08-08 Mark J. Malmros Biological stain composition, method of preparation and method of use for delineation of epithelial cancer
US6086852A (en) * 1997-11-13 2000-07-11 Zila, Inc. In vivo stain composition, process of manufacture, and methods of use to identify dysplastic tissue
US6194573B1 (en) * 1997-11-13 2001-02-27 Zila, Inc. Process for manufacture of in vivo stain composition
JP4424838B2 (ja) * 2000-08-31 2010-03-03 株式会社トクヤマ 四級アンモニウム塩の分析方法

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999025388A1 (en) * 1997-11-13 1999-05-27 Zila, Inc. In vivo stain composition, process of manufacture, and methods of use to identify dysplastic tissue
WO2001064255A1 (en) * 2000-02-28 2001-09-07 Zila, Inc. Method for detecting and killing epithelial cancer cells

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DARZYNKIEWICZ Z ET AL: "PHOTOSENSITIZING EFFECTS OF THE TRICYCLIC HETEROAROMATIC CATIONIC DYES PYRONIN Y AND TOLUIDINE BLUE O (TOLONIUM CHLORIDE)", CANCER RESEARCH, AMERICAN ASSOCIATION FOR CANCER RESEARCH, BALTIMORE, MD, US, vol. 48, no. 5, 1 March 1988 (1988-03-01), pages 1295 - 1299, XP000770930, ISSN: 0008-5472 *

Also Published As

Publication number Publication date
BRPI0215775A2 (pt) 2016-07-05
AU2002312319A1 (en) 2003-12-22
TW200733956A (en) 2007-09-16
CN1627961A (zh) 2005-06-15
EP1534346A2 (de) 2005-06-01
MXPA04012031A (es) 2005-03-07
WO2003103569A3 (en) 2004-05-21
JP2005535605A (ja) 2005-11-24
WO2003103569A2 (en) 2003-12-18
CN1302815C (zh) 2007-03-07
IL165516A0 (en) 2006-01-15

Similar Documents

Publication Publication Date Title
AU3692001A (en) Compositions and methods for enhancing drug delivery across biological membranesand tissues
AU2003239531A8 (en) Protein cages for the delivery of medical imaging and therapy
PL377687A1 (pl) Środki naśladujące ludzki peptyd glukagonopodobny typu 1 i ich zastosowanie w leczeniu cukrzycy i stanów związanych z cukrzycą
IL180434A0 (en) Human glucagon - like - peptide - 1 modulators and their use in the treatment of diabetes and related conditions
EP1594476A4 (de) Verfahren und vorrichtung zur behandlung von körpergewebe mit arzneistoffen
ZA200505272B (en) Treatment of skin wounds using polyenylphosphatidylcholine and alkanolamines
HUP0302726A3 (en) Methods of administering pharmaceutical composition containing epothilone analogs for the treatment of cancer and of preparation the same
EP1732462A4 (de) Elektromagnetische behandlung von gewebe und zellen
EP1385465A4 (de) Heterozyklische derivative zur behandlung von krebs und anderer proliferativer erkrankungen
DE60019814D1 (de) Pharmazeutische kombinationen enthaltend tegaserod und omeprazole und ihre verwendung zur behandlung gastrointestinaler krankheiten
AU2002341566A1 (en) Treatment and prevention of mucositis in cancer patients
IL161854A0 (en) Heterocyclic derivatives of glycinamide and their medical use
IL182352A (en) Use of et-743 in the preparation of a medicament for treating cancer and medical kits containing et-743
IS6966A (is) Cýanó-tengd díhýdrópýrimídín efnasambönd og notkun þeirra við meðhöndlun sjúkdóma
IS6967A (is) Ný cýanó-tengd díhýdrópýrimídín efnasambönd og notkun þeirra við meðhöndlun sjúkdóma
DE60107034D1 (de) Misch- und Ladeöffnung zur medizinischen Behandlung
EP1663377A4 (de) Therapeutisches medizinisches gerät, abgabe und anwendungsverfahren
AU2002253785A1 (en) Catheter and implants for the delivery of therapeutic agents to tissues
AU2003233681A8 (en) Diagnosis and treatment of human dormancy syndrome
IL165516A0 (en) Toluidine blue o drug substance and use thereof for in vivo staining and chemotherapeutic treatment of dysplastic tissues
ZA200610786B (en) Human glucagon-like-peptide-1 modulators and their use in the treatment of diabetes and related conditions
IL146794A0 (en) Osteonectin based toxic gene therapy for the treatment of calcified tumors and tissues
HUP0302535A3 (en) Peptide compounds, pharmaceutical compositions containing them and their use for treatment of no-mediated diseases
AU2003245858A1 (en) Uses of ngal-binding substances in the diagnosis and treatment of cancer diseases
NZ538926A (en) Medicament containing disorazoles and derivatives thereof for the treatment of benign and malignant tumoral diseases

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20050104

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

A4 Supplementary search report drawn up and despatched

Effective date: 20070621

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 31/5415 20060101AFI20070615BHEP

Ipc: A61K 49/00 20060101ALI20070615BHEP

Ipc: A61K 41/00 20060101ALI20070615BHEP

17Q First examination report despatched

Effective date: 20071022

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20100903